Monoclonal antibody shows promise in slowing progression of ALS

New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disease.

Opinion | ‘Boobs Are Overrated!’

“Boobs Are Overrated!” That’s what the card said. The card that arrived with the warm cookies. Let me back up. It all started with a

February 2, 2025

Lonza taps Siegfried leader Wolfgang Wienand as new CEO

Lonza named Wolfgang Wienand as its new CEO on Tuesday morning, replacing interim leader Albert Baehny this summer. Wienand has been with the CDMO Siegfried

April 3, 2024

AstraZeneca earmarks $1.5B for end-to-end ADC factory in Singapore

AstraZeneca said on Monday morning it is building a new antibody-drug conjugate facility in Singapore worth $1.5 billion. The UK pharma said this will be

May 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.